US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 244.890
- -1.910-0.77%
Close Nov 22 16:00 ET
- 244.400
- -0.490-0.20%
Post 20:01 ET
31.59BMarket Cap-93469P/E (TTM)
248.900High243.350Low526.15KVolume248.900Open246.800Pre Close129.12MTurnover0.41%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High975.66P/B31.45BFloat Cap141.97552wk Low--Dividend TTM128.44MShs Float304.390Historical High--Div YieldTTM2.25%Amplitude3.650Historical Low245.398Avg Price1Lot Size
About Alnylam Pharmaceuticals Company
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Company Profile
SymbolALNY
Company NameAlnylam Pharmaceuticals
Listing DateMay 27, 2004
Issue Price6.00
Founded2002
CEODr. Yvonne L Greenstreet, MB.Ch.B.
MarketNASDAQ
Employees2100
Fiscal Year Ends12-31
Address675 West Kendall Street,Henri A. Termeer Square
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-551-8200
Websitehttp://www.alnylam.com
Company Executives
- Name
- Position
- Salary
- Dr. Yvonne L Greenstreet, MB.Ch.B.
- Director and Chief Executive Officer
- 8.90M
- Kevin Joseph Fitzgerald, PhD
- Executive Vice President, Chief Scientific Officer and Head, Early Research and Early Development
- --
- Tolga Tanguler
- Chief Commercial Officer
- 2.87M
- Jeffrey V. Poulton
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 3.22M
- Dr. Pushkal P. Garg, M.D.
- Chief Medical Officer and Executive Vice President, Development and Medical Affairs
- 3.23M
- Dr. Akshay K. Vaishnaw, M.D.,PhD
- Chief Innovation Officer
- 3.32M
- Amy W. Schulman
- Chairman of the Board
- 531.36K
- Michael W. Bonney
- Director
- 467.23K
- David E.I. Pyott, M.B.A.,M.D.
- Independent Director
- 477.21K
- Dr. Phillip A. Sharp,PhD
- Independent Director
- 502.21K
- Dr. Margaret A. Hamburg, M.D.
- Independent Director
- 471.39K
- Dr. Dennis A. Ausiello, M.D.
- Independent Director
- 477.21K
- Dr. Carolyn R. Bertozzi, PhD
- Independent Director
- 668.94K
- Peter N. Kellogg
- Independent Director
- 658.72K
- Dr. Olivier Raymond Brandicourt, M.D.
- Independent Director
- 480.96K
- Colleen F. Reitan
- Independent Director
- 489.15K
- Dr. Elliott Sigal, M.D.,PhD
- Independent Director
- 470.11K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data